CRISPR-Cas systems provide prokaryotes with adaptive immunity against foreign plasmids and viruses. During the infection short fragments of invading nucleic acids can be integrated into the CRISPR region of host genome. The CRISPR region is transcribed and resulting transcript is processed into separate crRNA (CRISPR RNA) molecules. crRNAs together with Cas proteins assemble into effector complexes which guided by the crRNA seek and destroy foreign nucleic acids during subsequent infections. The best studied effector complexes of Type I and Type II CRISPR-Cas systems target invading DNA [1]. Type II effector complex comprising of a single Cas9 protein is widely established as genome editing tool [2]. In contrast, Type III effector Csm and Cmr complexes function as RNA-guided DNA nucleases: upon recognition of RNA target they start to degrade in cis both RNA and the DNA that is being transcribed [3]. It has been shown that Csm3 is the ribonuclease subunit of Csm complex [4] and Cas10 is the deoxyribonuclease which is activated upon the Csm complex binding to an RNA target [5]. However, the roles of remaining Csm complex subunits are not fully understood.
The aim of this study was to determine the functions of Streptococcus thermophilus CRISPR-Cas subtype III-A effector Csm complex (StCsm) subunits. For this reason we expressed in Escherichia coli and purified StCsm complexes lacking individual subunits. We analyzed i) the composition of StCsm complex in the deletion variants, ii) the RNA target binding affinity and cleavage rate, iii) the RNA-dependent DNA degradation rate. We show that Cas6 protein is responsible for S. thermophilus CRISPR transcript processing to individual crRNA molecules. Our data suggest that Csm4, which forms a subcomplex with deoxyribonuclease Cas10, specifically binds and anchors 5'-end of crRNA during the formation of StCsm complex. Next, we conclude that proteins Cas10, Csm4 and Csm5 are important for the maturation of crRNA. We also show how effector complex subunits promote the activity of StCsm. These results may pave the way for development of novel molecular tool for programmable RNA silencing both in vitro and in vivo.